The Post-ASH blog is always a challenge and one that takes the longest. I like to gather my notes, review my many tweets, and think about what struck me as most exciting to share with you and my local support group members. I encourage you to check out ALL the tweets from #ASH16. Two of […]
Each year I’m honored to attend ASH with the IMF. I’ve been a myeloma survivor for 16 years and am encouraged to continue to share all the good news from ASH. When I first attended ASH with the IMF about 10 years ago, there were not nearly as many trials as we have now. It […]
In this video, patient advocate and active member of the Philadelphia Multiple Myeloma Networking Group Cindy Chmielewski says that she “couldn’t imagine how this year’s meeting could compare to last year’s ASH, or the ‘November to Remember.’” She points out drugs she learned about at this year’s meeting used to treat relapsed/refractory multiple myeloma patients: […]
Saturday night ended with a very successful IMF Media and Grant Awards Reception, at the Ultimate Skybox, with a 15th floor view of the Petco Park playing field on one side, and Seaport Village and the harbor on another. Robert A. Kyle, MD, presented the Brian D. Novis Research Grant Awards. I was happy to […]
Today’s events began with 9:30 a.m. education program on 1) managing Newly Diagnosed High-Risk (HR) Multiple Myeloma patients 2) Sequencing treatments, and 3) the role of stem cell transplant (SCT) and maintenance. Dr Angela Dispenzieri spoke on the first topic, and she reminded the audience that “High-Risk” doesn’t just mean cytogenetic factors like del(17p), but […]
Each year, ASH comes on the heels of Thanksgiving, which is one of my favorite holidays. It’s the perfect opportunity to reflect on all there is to be thankful for, including all the research being done in our myeloma world. When I was diagnosed with myeloma in 2000, the options were few and side effects […]
